Profiling metabolic remodeling in PP2Acα deficiency and chronic pressure overload mouse hearts

被引:13
作者
Dong, Dachuan [1 ]
Li, Liangyuan [1 ]
Gu, Pengyu [2 ]
Jin, Tao [1 ]
Wen, Mingda [1 ]
Yuan, Caihua [1 ]
Gao, Xiang [2 ]
Liu, Chang [1 ]
Zhang, Zhao [1 ]
机构
[1] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing 210023, Jiangsu, Peoples R China
[2] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Protein phosphatase 2a; Myocardial energetics; Heart failure; Transcriptional profiling; PROTEIN PHOSPHATASE 2A; FATTY-ACID OXIDATION; CORONARY-ARTERY-DISEASE; CATALYTIC SUBUNIT; FAILING HEART; SERINE/THREONINE PHOSPHATASES; FAILURE; DYSFUNCTION; MITOCHONDRIA; HYPERTROPHY;
D O I
10.1016/j.febslet.2015.10.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Our understanding of how metabolic switches occur in the failing heart is still limited. Here, we report the emblematic pattern of metabolic alternations in two different mouse models. PP2Ac alpha deficient hearts exhibited a dramatic decrease in the levels of mRNA encoding for transporters and enzymes involved in glucose utilization, which compensated by higher expression levels of genes controlling fatty acid utilization. These features were partly reproduced in cultured PP2Ac alpha KD cardiomyocytes. Equivalently, a decrease in the expression of most of the transporters and enzymes controlling both glucose and fatty acid metabolism were observed in TAC model. (C) 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:3631 / 3639
页数:9
相关论文
共 42 条
[1]   GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle [J].
Aerni-Flessner, Lauren ;
Abi-Jaoude, Melissa ;
Koenig, Amanda ;
Payne, Maria ;
Hruz, Paul W. .
CARDIOVASCULAR DIABETOLOGY, 2012, 11
[2]   Cardiac dysfunction and pen-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity [J].
Aksentijevic, Dunja ;
McAndrew, Debra J. ;
Karlstaedt, Anja ;
Zervou, Sevasti ;
Sebag-Montefiore, Liams ;
Cross, Rebecca ;
Douglas, Gillian ;
Regitz-Zagrosek, Vera ;
Lopaschuk, Gary D. ;
Neubauer, Stefan ;
Lygate, Craig A. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2014, 75 :76-87
[3]   ERRγ directs and maintains the transition to oxidative metabolism in the postnatal heart [J].
Alaynick, William A. ;
Kondo, Richard P. ;
Xie, Wen ;
He, Weimin ;
Dufour, Catherine R. ;
Downes, Michael ;
Jonker, Johan W. ;
Giles, Wayne ;
Naviaux, Robert K. ;
Giguere, Vincent ;
Evans, Ronald M. .
CELL METABOLISM, 2007, 6 (01) :13-24
[4]   PRINCIPAL SUBSTRATES OF FETAL METABOLISM [J].
BATTAGLIA, FC ;
MESCHIA, G .
PHYSIOLOGICAL REVIEWS, 1978, 58 (02) :499-527
[5]   Mitochondria as a Therapeutic Target in Heart Failure [J].
Bayeva, Marina ;
Gheorghiade, Mihai ;
Ardehali, Hossein .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (06) :599-610
[6]   Dilated cardiomyopathy in transgenic mice expressing a mutant A subunit of protein phosphatase 2A [J].
Brewis, N ;
Ohst, K ;
Fields, K ;
Rapacciuolo, A ;
Chou, D ;
Bloor, C ;
Dillmann, W ;
Rockman, H ;
Walter, G .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (03) :H1307-H1318
[7]   Accuracy of echocardiographic estimates of left ventricular mass in mice [J].
Collins, KA ;
Korcarz, CE ;
Shroff, SG ;
Bednarz, JE ;
Fentzke, RC ;
Lin, H ;
Leiden, JM ;
Lang, RM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 280 (05) :H1954-H1962
[8]   Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy [J].
Depre, C ;
Shipley, GL ;
Chen, WH ;
Han, QY ;
Doenst, T ;
Moore, ML ;
Stepkowski, S ;
Davies, PJA ;
Taegtmeyer, H .
NATURE MEDICINE, 1998, 4 (11) :1269-1275
[9]   Cardiac Metabolism in Heart Failure Implications Beyond ATP Production [J].
Doenst, Torsten ;
Tien Dung Nguyen ;
Abel, E. Dale .
CIRCULATION RESEARCH, 2013, 113 (06) :709-724
[10]   Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy [J].
Fillmore, N. ;
Mori, J. ;
Lopaschuk, G. D. .
BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (08) :2080-2090